1490 related articles for article (PubMed ID: 23665962)
1. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
Commisso C; Davidson SM; Soydaner-Azeloglu RG; Parker SJ; Kamphorst JJ; Hackett S; Grabocka E; Nofal M; Drebin JA; Thompson CB; Rabinowitz JD; Metallo CM; Vander Heiden MG; Bar-Sagi D
Nature; 2013 May; 497(7451):633-7. PubMed ID: 23665962
[TBL] [Abstract][Full Text] [Related]
2. EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis.
Lee SW; Zhang Y; Jung M; Cruz N; Alas B; Commisso C
Dev Cell; 2019 Aug; 50(3):381-392.e5. PubMed ID: 31257175
[TBL] [Abstract][Full Text] [Related]
3. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.
Ramirez C; Hauser AD; Vucic EA; Bar-Sagi D
Nature; 2019 Dec; 576(7787):477-481. PubMed ID: 31827278
[TBL] [Abstract][Full Text] [Related]
4. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.
Du Y; Shang BY; Sheng WJ; Zhang SH; Li Y; Miao QF; Zhen YS
Oncotarget; 2016 Sep; 7(36):58418-58434. PubMed ID: 27517152
[TBL] [Abstract][Full Text] [Related]
5. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.
Sung S; Choi J; Cheong H
Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954
[TBL] [Abstract][Full Text] [Related]
6. Metabolism: Taking it all in.
Seton-Rogers S
Nat Rev Cancer; 2013 Jul; 13(7):438. PubMed ID: 23739049
[No Abstract] [Full Text] [Related]
7. The pervasiveness of macropinocytosis in oncological malignancies.
Commisso C
Philos Trans R Soc Lond B Biol Sci; 2019 Feb; 374(1765):20180153. PubMed ID: 30967003
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer.
Xiong X; Rao G; Roy RV; Zhang Y; Means N; Dey A; Tsaliki M; Saha S; Bhattacharyya S; Dhar Dwivedi SK; Rao CV; McCormick DJ; Dhanasekaran D; Ding K; Gillies E; Zhang M; Yang D; Bhattacharya R; Mukherjee P
FASEB J; 2020 Sep; 34(9):12024-12039. PubMed ID: 32692445
[TBL] [Abstract][Full Text] [Related]
9. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Davidson SM; Jonas O; Keibler MA; Hou HW; Luengo A; Mayers JR; Wyckoff J; Del Rosario AM; Whitman M; Chin CR; Condon KJ; Lammers A; Kellersberger KA; Stall BK; Stephanopoulos G; Bar-Sagi D; Han J; Rabinowitz JD; Cima MJ; Langer R; Vander Heiden MG
Nat Med; 2017 Feb; 23(2):235-241. PubMed ID: 28024083
[TBL] [Abstract][Full Text] [Related]
11. Detection and Quantification of Macropinosomes in Pancreatic Tumors.
Lee SW; Alas B; Commisso C
Methods Mol Biol; 2019; 1882():171-181. PubMed ID: 30378054
[TBL] [Abstract][Full Text] [Related]
12. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
Son J; Lyssiotis CA; Ying H; Wang X; Hua S; Ligorio M; Perera RM; Ferrone CR; Mullarky E; Shyh-Chang N; Kang Y; Fleming JB; Bardeesy N; Asara JM; Haigis MC; DePinho RA; Cantley LC; Kimmelman AC
Nature; 2013 Apr; 496(7443):101-5. PubMed ID: 23535601
[TBL] [Abstract][Full Text] [Related]
13. Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer.
Recouvreux MV; Commisso C
Front Endocrinol (Lausanne); 2017; 8():261. PubMed ID: 29085336
[TBL] [Abstract][Full Text] [Related]
14. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.
Kamphorst JJ; Nofal M; Commisso C; Hackett SR; Lu W; Grabocka E; Vander Heiden MG; Miller G; Drebin JA; Bar-Sagi D; Thompson CB; Rabinowitz JD
Cancer Res; 2015 Feb; 75(3):544-53. PubMed ID: 25644265
[TBL] [Abstract][Full Text] [Related]
15. RAS-Driven Macropinocytosis of Albumin or Dextran Reveals Mutation-Specific Target Engagement of RAS p.G12C Inhibitor ARS-1620 by NIR-Fluorescence Imaging.
Sutton MN; Gammon ST; Muzzioli R; Pisaneschi F; Radaram B; Yang P; Piwnica-Worms D
Mol Imaging Biol; 2022 Jun; 24(3):498-509. PubMed ID: 34905147
[TBL] [Abstract][Full Text] [Related]
16. Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation.
Elechalawar CK; Rao G; Gulla SK; Patel MM; Frickenstein A; Means N; Roy RV; Tsiokas L; Asfa S; Panja P; Rao C; Wilhelm S; Bhattacharya R; Mukherjee P
ACS Nano; 2023 May; 17(10):9326-9337. PubMed ID: 37129853
[TBL] [Abstract][Full Text] [Related]
17. High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis.
Fennell M; Commisso C; Ramirez C; Garippa R; Bar-Sagi D
Assay Drug Dev Technol; 2015 Sep; 13(7):347-55. PubMed ID: 26267765
[TBL] [Abstract][Full Text] [Related]
18. Macropinocytosis in Cancer-Associated Fibroblasts Is Dependent on CaMKK2/ARHGEF2 Signaling and Functions to Support Tumor and Stromal Cell Fitness.
Zhang Y; Recouvreux MV; Jung M; Galenkamp KMO; Li Y; Zagnitko O; Scott DA; Lowy AM; Commisso C
Cancer Discov; 2021 Jul; 11(7):1808-1825. PubMed ID: 33653692
[TBL] [Abstract][Full Text] [Related]
19. A Macropinocytosis-Intensifying Albumin Domain-Based scFv Antibody and Its Conjugate Directed against K-Ras Mutant Pancreatic Cancer.
Wang X; Sheng W; Wang Y; Li L; Li Y; Zhang S; Liu X; Chen S; Zhen Y
Mol Pharm; 2018 Jun; 15(6):2403-2412. PubMed ID: 29757658
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
